Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

The purpose of this study is to determine whether Bimosiamose Cream is safe and effective in the treatment of plaque type psoriasis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psoriasis Skin Diseases Skin Diseases, Papulosquamous Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Charité Campus Mitte, Klinik für Dermatologie, Venerologie und Allergologie

Berlin, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of plaque type psoriasis PASI score of 5-15
At least 18 years of age
Written informed consent

Exclusion criteria

Active skin infection
More than 20% Body Surface Area (BSA) affected by psoriasis
Use of certain anti-psoriasis medication or treatments

Treatment and study plan

Bimosiamose Cream

Drug

placebo cream

Drug

Sponsors and collaborators

Lead sponsor

Revotar Biopharmaceuticals AG

Industry

Registry information

Official study title

Multi-center, Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Bimosiamose 5% Cream for the Treatment of Patients With Chronic Plaque Type Psoriasis

Important dates

First posted: Jan 16, 2009
Registry last updated: Aug 21, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed